Table 2.
Combined application of rosmarinic acid and derivatives with other antimicrobial agents.
| Rosmarinic Acid with | Microorganisms | Synergy | References |
|---|---|---|---|
| Vancomycin | Staphylococcus aureus | + | [182] |
| Ofloxacin | Staphylococcus aureus | + | |
| Amoxicillin | Staphylococcus aureus | + | |
| Vancomycin | MRSA | + | |
| Ofloxacin | MRSA | − | |
| Amoxicillin | MRSA | − | |
| Penicillin | MRSA | + | [220] |
| Methyl rosmarinate | Staphylococcus epidermidis 5001 | − | [77] |
| Stenotrophomonas maltophilia | − | ||
| Enterococcus faecalis C159-6 | − | ||
| Staphylococcus lugdunensis T26A3 | − | ||
| Pseudomonas aeruginosa ATCC 27583 | + | ||
| Corynebacterium T25-17 | − | ||
| Mycobacterium smegmatis 5003 | − | ||
| Staphylococcus warneri T12A12 | − | ||
| Isoquercetin | Staphylococcus epidermidis 5001 | − | |
| Stenotrophomonas maltophilia | − | ||
| Enterococcus faecalis C159-6 | − | ||
| Staphylococcus lugdunensis T26A3 | − | ||
| Pseudomonas aeruginosa ATCC 27583 | − | ||
| Corynebacterium T25-17 | − | ||
| Mycobacterium smegmatis 5003 | − | ||
| Staphylococcus warneri T12A12 | − | ||
| Hyperoside | Staphylococcus epidermidis 5001 | − | |
| Stenotrophomonas maltophilia | − | ||
| Enterococcus faecalis C159-6 | − | ||
| Staphylococcus lugdunensis T26A3 | − | ||
| Pseudomonas aeruginosa ATCC 27583 | − | ||
| Corynebacterium T25-17 | − | ||
| Mycobacterium smegmatis 5003 | + | ||
| Staphylococcus warneri T12A12 | + | ||
| Ulvan | COVID-19 | + | [221] |
| Chitosan | Escherichia coli | + | [223] |
| Polyvlactic acid/layered double hydroxides-Rosmarinic acid | Escherichia coli | + | [224] |
| Staphylococcus aureus | + | ||
| FeIII/MoO42/PO43 | herpes simplex virus | + | [225] |
| VSV-Ebola pseudotypes | + |